Marathon Venture Partners

Marathon Venture Partners is a Beijing-based venture capital firm established in 2016. It specializes in investing in early and growth-stage companies within the healthcare and financial technology sectors. The firm aims to support innovative businesses that are poised for significant development and impact in these industries. By focusing on these high-potential areas, Marathon Venture Partners seeks to foster advancements that can improve healthcare delivery and financial services.

Vincent Chan

Venture Partner

Donald Gao

Partner

Yiran Song

Managing Director

Yinan Tang

Managing Director

33 past transactions

Botong Health

Angel Round in 2022
Botong Medical is a comprehensive service platform created for the management of cancer pain. The business's data platform, digital medical goods, focuses on intelligent pain assessment, fracture risk prediction, chronic pain management, and rehabilitation. It offers stepped pain treatment services to both cancer pain patients and chronic pain patients.
Doctor AI is a med-tech firm that provides a smart AI medical record quality control system.

Connect Medical Value

Series A in 2021
Connect Medical Value is a company that creates mobile apps for physicians. Founded in 2020 and is based in Hangzhou, Zhejiang, China.

MediTrust Health

Series B in 2021
Shanghai MediTrust Health Technology Co., Ltd. provides help to patients solve its medical expenses through financial insurance. The firm is based in Shanghai, China.

Singular Medical

Series B in 2021
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Singular Medical

Series A in 2020
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Xunshi Technology

Series B in 2019
Zhejiang Xunshi Technology Co., Ltd. specializes in the development and manufacturing of 3D printers, printing consumables, and 3D scanners. The company offers a range of desktop printers tailored for specific sectors, including the MoonRay D for dental applications, MoonRay J for jewelry, and MoonRay S for educational purposes. Its industrial printer lineup features the SLA laser rapid prototyping printer, the SolarRay DLP 3D printer, and ceramic 3D printers such as the CeraRay CR-I and CeraRay TC-I. Additionally, Xunshi produces 3D architectural printers designed for contour crafting and provides photosensitive resin and photocurable wax products for dentistry, jewelry, and ceramics. The company's desktop scanners serve various applications in dental medicine, education, research, and industry. Established in 2013, Xunshi Technology is headquartered in Shaoxing, China.
anghai Ruiyi Biotechnology Co., Ltd. was established in Shanghai in 2014 and is a national high-tech enterprise. At present, it has established branches in Hangzhou, Qingdao and Guiyang. It is a professional genetic technology and health service company. The company has always been adhering to the corporate philosophy of "forge ahead" and is committed to providing customers with the highest quality products and services. Since its inception, Shanghai Ruiyi Biotechnology Co., Ltd. has quickly established cooperation with many well-known research institutes at home and abroad, and has attracted many elites from the fields of genomics, medicine and bioinformatics. Up to now, the company has obtained more than 40 software copyrights and a number of patents.

Shukun

Series B in 2019
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

DaoCloud

Series B in 2018
Shanghai DaoCloud Network Technology Co., Ltd., founded in 2014, is a cloud computing company specializing in docker services for mobile application developers. The company provides a comprehensive platform that supports the entire lifecycle of cloud-native applications, encompassing development, delivery, and operation across public, private, and hybrid cloud environments. DaoCloud's advanced technology facilitates continuous integration and automation, enabling clients to enhance their application delivery processes and achieve omnichannel accessibility. The company has garnered a strong reputation in various industries, including finance, automotive, and energy, serving notable clients such as the People's Bank and Haier Group. With a dedicated team and an expanding workforce of over 300 employees across multiple branches in China, DaoCloud is committed to driving digital transformation for enterprises in the modern internet era.

GrandOmics

Series B in 2018
Grandomics Biosciences Co., Ltd. is a precision medical company based in Beijing, China, specializing in genetic sequencing and diagnosis. Founded in 2014, Grandomics offers a range of solutions for monogenic diseases, including Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), and multiplex ligation-dependent probe amplification. The company also focuses on specific disorders such as facioscapulohumeral muscular dystrophy. In addition to these diagnostic services, Grandomics provides advanced sequencing platforms like Oxford Nanopore and Pacbio Sequel, along with GrandBox™, a software suite for clinical sample management and data analysis. This integrated approach enables comprehensive genetic testing and carrier screening, positioning Grandomics as a key player in the field of molecular diagnosis and genetic research.

Shukun

Series A in 2018
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Nanos Medical

Series B in 2018
Nanos Medical is engaged in the research and development, manufacturing and sales of disposable medical devices. The company's current core products are concentrated in the cardiovascular and ENT fields.

Vedeng

Series A in 2018
Nanjing Vedeng Biotechnology Co., Ltd. is a Chinese company that specializes in the distribution of medical equipment. It operates a platform that connects upstream manufacturers with medical equipment dealers and private clinics. Vedeng has developed a comprehensive digital infrastructure that includes front-end marketing, procurement systems, logistics, after-sales service, and back-end commodity databases. This infrastructure supports a vast network of approximately 970,000 grassroots and private medical customers, facilitating efficient communication and transactions within the medical equipment sector.

MediTrust Health

Angel Round in 2018
Shanghai MediTrust Health Technology Co., Ltd. provides help to patients solve its medical expenses through financial insurance. The firm is based in Shanghai, China.

V-Joy Tech

Series A in 2018
V-Joy Tech, which operates under Gongziqianbao.com, is a Shanghai-based salary management service provider.

Hofon Medical Care

Series A in 2018
Zhejiang Hofon Medical Care Co., Ltd. is a healthcare support company based in Hangzhou, China, that specializes in developing software solutions for the medical sector. The company provides a range of services including patient management, online ordering, marketing, doctor-patient communication, and statistical data analysis. Hofon Medical Care focuses on addressing the health needs of community residents through an integrated online and offline medical service model. This model facilitates disease diagnosis and treatment, home-based medical care, chronic disease management, and health management services. By offering these comprehensive services, the company aims to enhance the accessibility, efficiency, and quality of healthcare for patients in their local communities.

Huangjinguanjia

Series B in 2018
Huangjinguanjia is an online financial service platform based in Beijing, China, specializing in gold trading and investment. The company offers a range of financial services that facilitate the buying and selling of gold, catering to individuals and investors interested in this precious metal. Through its platform, Huangjinguanjia aims to provide users with accessible tools and resources for engaging in gold investment, contributing to the broader financial market in China.

Cihon

Series B in 2018
Cihon is a data provider focused on the automotive industry, offering a data intelligence platform designed to serve car manufacturers and insurance companies. The platform delivers comprehensive data analytics on vehicles, auto parts, and vehicle owners, allowing clients to enhance their business operations. By supplying valuable insights, Cihon helps automotive stakeholders make informed decisions and improve their overall performance.

JuniperMD

Angel Round in 2018
JuniperMD Inc., a disease management service organization, integrates the medical resources of the United States, Australia, Japan, and Europe with collaboration, professional knowledge, processes, and practical technology for China. It offers one-stop disease management solutions, including overseas medical examination, pathological examination, remote diagnosis and consultation, overseas medical treatment and follow-up services from the perspective of prevention, investigation, diagnosis, treatment, and more. The company was founded in 2016 and is based in Beijing, China with subsidiaries or branches in Guangzhou, Shanghai, New York, Boston, Chicago, Houston, and other urban communities.

Lion Rock FinTech

Series A in 2017
Lion Finance provides services related to investment, information origination/aggregation, and machine-learning recommendation.

Yidebang

Series A in 2017
Yidebang is a Beijing-based healthcare software developer, which provides management solution, drug supply, hierarchical diagnosis and treatment and other supporting medical services for basic-level clinics in China.

AnchorDx

Series B in 2017
AnchorDx is a company focused on advancing precision medicine through its development of next-generation sequencing techniques, particularly utilizing molecular liquid biopsies. This approach offers non-invasive access to genetic information, enabling patients to gain insights into their physiological conditions and prepare for potential future health issues. With a core team boasting over 20 years of experience in cancer genomics, genetics, and bioinformatics, AnchorDx aims to establish itself as a leading global provider of precision medical solutions. The company collaborates with various middle and downstream enterprises, fostering a comprehensive industrial chain that spans from academic research to clinical product transformation. Additionally, AnchorDx has formed partnerships with numerous large-scale third-party inspection agencies, hospitals, and research institutes, contributing to the development of independent intellectual property rights and competitive clinical testing products that deliver accurate and comprehensive services to patients, doctors, and medical institutions.

Helian Health

Series A in 2017
Helian Health, established in 2014 and based in Hangzhou, China, specializes in providing Wi-Fi services to hospitals and developing online healthcare platforms that cater to both patients and healthcare professionals. The company has created several applications, such as Xiaohe Yizhu, which enables healthcare providers to store health records in the cloud and share medical case studies, and Hejiankang, designed for companies to offer personalized health recommendations to their employees. Helian Health has built a substantial platform serving over 1,700 hospitals across 245 cities, including many top-tier hospitals, and has achieved a significant presence in the medical Internet of Things (IoT) sector. The company also collaborates with equipment manufacturers to implement IoT solutions that enhance hospital operations, thereby improving service efficiency and reducing costs. Through its commitment to creating comprehensive health services, Helian Health aims to leverage technology to promote healthier living and contribute to the advancement of medical care.

Baozhunniu

Series B in 2017
Baozhunniu is an online insurance platform that provides customized insurance products.

Shukun

Angel Round in 2017
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

GEvent Financial Service

Series A in 2017
GEVent Financial Service is a financial services company located in Nanjing, China. It specializes in providing internet-based financial solutions aimed at facilitating bank financing for both banks and non-bank financial institutions. The company's offerings include a range of financial and technical services that support various aspects of banking, wealth management, and online exchanges. Through its technology-driven products, GEvent Financial Service enables financial institutions to enhance their service delivery and operational efficiency.

AnchorDx

Series A in 2015
AnchorDx is a company focused on advancing precision medicine through its development of next-generation sequencing techniques, particularly utilizing molecular liquid biopsies. This approach offers non-invasive access to genetic information, enabling patients to gain insights into their physiological conditions and prepare for potential future health issues. With a core team boasting over 20 years of experience in cancer genomics, genetics, and bioinformatics, AnchorDx aims to establish itself as a leading global provider of precision medical solutions. The company collaborates with various middle and downstream enterprises, fostering a comprehensive industrial chain that spans from academic research to clinical product transformation. Additionally, AnchorDx has formed partnerships with numerous large-scale third-party inspection agencies, hospitals, and research institutes, contributing to the development of independent intellectual property rights and competitive clinical testing products that deliver accurate and comprehensive services to patients, doctors, and medical institutions.

GEvent Financial Service

Angel Round in 2014
GEVent Financial Service is a financial services company located in Nanjing, China. It specializes in providing internet-based financial solutions aimed at facilitating bank financing for both banks and non-bank financial institutions. The company's offerings include a range of financial and technical services that support various aspects of banking, wealth management, and online exchanges. Through its technology-driven products, GEvent Financial Service enables financial institutions to enhance their service delivery and operational efficiency.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.